[ACRX] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
17-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 261.74%
YoY- 268.87%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 6,435 1,730 226 27,607 1,675 624 0 -
PBT -9,682 -10,558 -13,818 17,769 -33,363 -20,101 -14,344 -6.33%
Tax 68 -12 -1,218 -1,742 -22,841 -13,728 -10,819 -
NP -9,682 -10,546 -13,818 17,769 -10,522 -6,372 -3,523 18.33%
Tax Rate - - - 9.80% - - - -
Total Cost 16,117 12,276 14,044 9,838 12,197 6,996 3,523 28.81%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -150.46 -609.60 -6,114.16 64.36 -628.18 -1,021.15 0.00 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -4.27 -4.66 -6.30 8.20 -5.67 -6.50 -6.56 -6.90%
EPS Diluted -4.27 -4.66 -6.22 8.20 -5.67 -6.50 -6.56 -6.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.